Fagron’s share buy-back program: Weekly update
30 Août 2024 - 6:34PM
UK Regulatory
Fagron’s share buy-back program: Weekly update
Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 30 August 2024 –
6PM CET
Fagron’s share buy-back program: Weekly
update
In the period from 26 August 2024 through 30 August 2024, Fagron
purchased 37,000 of its own shares at an average price of € 18.99
per share corresponding to a total amount of € 1,357,476.41.
These purchases are part of the share buy-back program of up to
150,000 Fagron shares to fulfill Fagron’s obligations under its
long-term incentive scheme, which was announced on 1 August
2024.
The total number of own shares purchased to date is 71,500.
More information, including a detailed overview of the purchase
transactions under this program, is available on our share buy-back
webpage.
Financial calendar 2024
10 October
2024 Trading update
third quarter 2024
Results and trading updates are published at 7.00 AM CET.
Further information
Karin de Jong
Chief Financial Officer
investors@fagron.com
About Fagron
Fagron is a leading global company active in pharmaceutical
compounding, focusing on delivering personalized medicine to
hospitals, pharmacies, clinics and patients in more than 30
countries around the world.
Belgian company Fagron NV has its registered office in Nazareth
and is listed on Euronext Brussels and Euronext Amsterdam under the
ticker symbol ‘FAGR’. Fagron’s operational activities are managed
by the Dutch company Fagron BV, which is headquartered in
Rotterdam.
In the event of differences between the English translation
and the Dutch original of this press release, the latter
prevails.
- Fagron’s share buy-back program Weekly update
Fagron NV (EU:FAGR)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Fagron NV (EU:FAGR)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024